BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18491405)

  • 1. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
    Bonovas S; Filioussi K; Sitaras NM
    Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.
    Bonovas S; Filioussi K; Sitaras NM
    Am J Gastroenterol; 2008 Oct; 103(10):2646-51. PubMed ID: 18684187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies.
    Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Deng Y; Peng Q; Li S; Qin X
    Cancer Causes Control; 2014 Feb; 25(2):237-49. PubMed ID: 24265089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and risk of prostate cancer: a meta-analysis of observational studies.
    Bansal D; Undela K; D'Cruz S; Schifano F
    PLoS One; 2012; 7(10):e46691. PubMed ID: 23049713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and risk of pancreatic cancer: a meta-analysis.
    Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
    Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and risk of bladder cancer: a meta-analysis.
    Zhang XL; Geng J; Zhang XP; Peng B; Che JP; Yan Y; Wang GC; Xia SQ; Wu Y; Zheng JH
    Cancer Causes Control; 2013 Apr; 24(4):769-76. PubMed ID: 23361339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
    Liu Y; Qin A; Li T; Qin X; Li S
    Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.
    Bonovas S; Filioussi K; Tsantes A; Sitaras NM
    Br J Clin Pharmacol; 2007 Sep; 64(3):255-62. PubMed ID: 17578480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials.
    Zhang XL; Liu M; Qian J; Zheng JH; Zhang XP; Guo CC; Geng J; Peng B; Che JP; Wu Y
    Br J Clin Pharmacol; 2014 Mar; 77(3):458-65. PubMed ID: 23879311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study.
    Lustman A; Nakar S; Cohen AD; Vinker S
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):6-9. PubMed ID: 24061633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.
    Tan P; Wei S; Tang Z; Gao L; Zhang C; Nie P; Yang L; Wei Q
    Sci Rep; 2016 Apr; 6():24521. PubMed ID: 27075437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.
    Wang J; Li C; Tao H; Cheng Y; Han L; Li X; Hu Y
    PLoS One; 2013; 8(10):e77950. PubMed ID: 24205041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of statin dosing intensity on transaminase and creatine kinase.
    Dale KM; White CM; Henyan NN; Kluger J; Coleman CI
    Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.